To combat swine fever, China moved pig farming into massive, 26-story buildings. This industrial efficiency worked too well, creating a pork oversupply that crashed prices to a 15-year low. This highlights the risk of centralized, top-down industrial planning that can dramatically overshoot market demand and cause industry-wide losses.

Despite flat commodity prices and rampant inflation in land and equipment costs, American farmers have remained solvent over the last decade primarily through immense productivity gains. Rapid adoption of technology has continually lowered their per-unit production costs, allowing them to survive on thinning margins.

The Froyo industry's previous decline wasn't due to a lack of demand, but a surplus of supply. The business model—low-cost self-serve machines and minimal labor needs—was so attractive and easy to replicate that it led to oversaturation. The industry essentially became a victim of its own success.

A record harvest of corn and soybeans, coupled with lower demand from China, created a surplus of turkey feed. This supply chain effect directly lowered input costs for farmers, resulting in a significant 14% Thanksgiving turkey price drop for end consumers.

China is poised to create a microcycle in chemicals by moving up the value chain to compete on quality, not just cost. This will create massive overcapacity and upend a global industry that seems unprepared for the coming upheaval.

China is replicating its state-driven model for industries like automotive in bioprocessing. However, Chinese firms themselves recognize that simply copying Western methods is unprofitable. This creates a global race where both Western and Chinese companies must innovate on process technology, not just cost, to gain a competitive edge.

In response to deflation and eroding profits from hyper-competition, the Chinese government's "anti-evolution" policy is a deliberate strategy to force consolidation, reduce overcapacity, and restore pricing power, thereby boosting corporate return on equity.

China's economic structure, which funnels state-backed capital into sectors like EVs, inherently creates overinvestment and excess capacity. This distorted cost of capital leads to hyper-competitive industries, making it difficult for even successful companies to generate predictable, growing returns for shareholders.

The old narrative of China's IP theft is outdated. Today, China's competitive advantage in sectors like biotech comes from its massive scale, significant resources, and collective lack of profit sensitivity. This combination allows it to dominate industries and destroy profitability for other global players, as previously seen in solar and EVs.